Directory
>
Stanley Erck
Stanley Erck
Advisor to the Board of Directors, Former CEO | Novavax
Bluffton, South Carolina, United States
Stanley Erck
Summary
Stanley Erck is a seasoned advisor and board member with extensive experience in the biotechnology sector, notably as a former CEO. He has successfully guided multiple products through critical phases of clinical trials, particularly in infectious diseases and vaccines. His career highlights include leading companies from startup stages through to IPOs and strategic acquisitions. Stanley possesses a strong background in immunology, autoimmune diseases, and genetic diseases, underscoring his expertise in addressing complex health challenges. He has served on the boards of various biotechnology firms, contributing valuable insights and strategic direction. With an MBA from the University of Chicago Booth School of Business, he combines financial acumen with scientific knowledge, making him a formidable leader in the industry. Stanley's passion for innovation and strategic planning continues to drive his contributions to biotechnology.
Stanley Erck
Work Experience
Advisor to the Board of Directors, Former CEO at
Novavax
January 2009 - Present
Member, Board of Directors at
MaxCyte, Inc.
January 2006 - Present
Member, Board of Directors at
BIOCRYST IRELAND LIMITED
March 2008 - October 2018
CEO at
Iomai Corporation
January 2000 - January 2008
CEO at
Valneva
January 2000 - January 2008
CEO at
PHT Corporation
January 1999 - January 2000
CEO at
Procept Associates Ltd.
January 1988 - January 1998
Vice President Corporate Development Integrated Genetics at
Genzyrne Genetic
September 1983 - December 1988
Vice President, Corporate Development at
Integrated Genetics
January 1983 - January 1988
Stanley Erck
Education
University of Chicago Booth School of Business, Mba
January 1973 - January 1976
Frequently Asked Questions about Stanley Erck
What is Stanley Erck email address?
Stanley Erck's primary email address is *****@maxcyte.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Stanley Erck work for?
Stanley Erck is a Advisor to the Board of Directors, Former CEO at Novavax, a company specializing in Biological products, except diagnostic.
Where Stanley Erck graduated from?
Stanley Erck holds a degree in Economics, Finance from University of Chicago Booth School of Business.
How can I directly contact Stanley Erck?
To contact Stanley Erck directly, you can use the email address *****@maxcyte.com. Complete contact information is available upon registration with Muraena.
Who is Stanley Erck?
Stanley Erck is a seasoned advisor and board member with extensive experience in the biotechnology sector, notably as a former CEO. He has successfully guided multiple products through critical phases of clinical trials, particularly in infectious diseases and vaccines. His career highlights include leading companies from startup stages through to IPOs and strategic acquisitions. Stanley possesses a strong background in immunology, autoimmune diseases, and genetic diseases, underscoring his expertise in addressing complex health challenges. He has served on the boards of various biotechnology firms, contributing valuable insights and strategic direction. With an MBA from the University of Chicago Booth School of Business, he combines financial acumen with scientific knowledge, making him a formidable leader in the industry. Stanley's passion for innovation and strategic planning continues to drive his contributions to biotechnology.
Stanley`s contact details
*****@maxcyte.com
*****@biocryst.com
*****@novavax.com
Colleagues
Vice President, Vaccine Immunology
Vice President Global Quality Assurance
Senior Calibration Technician
Quality Assurance Specialist III CMO | OJT Trainer | Quality Operations
Vice President, Vaccine Development
Vice President, Head of Global Medical Writing and Clinical Trial Transparency
President, Research and Development
Executive Director Clinical Outsourcing & Business Operations
SVP Commercial Operations
Senior Vice President and Chief Medical Officer